首页 | 本学科首页   官方微博 | 高级检索  
     


Regulation of the cardiac sodium pump
Authors:W. Fuller  L. B. Tulloch  M. J. Shattock  S. C. Calaghan  J. Howie  K. J. Wypijewski
Affiliation:1. Division of Cardiovascular and Diabetes Medicine, Medical Research Institute, College of Medicine Dentistry and Nursing, University of Dundee, Dundee, UK
4. Division of Cardiovascular and Diabetes Medicine, Ninewells Hospital, Mail Box 12, Level 5, Dundee, DD1 9SY, UK
2. Cardiovascular Division, King’s College London, London, UK
3. School of Biomedical Sciences, University of Leeds, Leeds, LS2 9JT, UK
Abstract:In cardiac muscle, the sarcolemmal sodium/potassium ATPase is the principal quantitative means of active transport at the myocyte cell surface, and its activity is essential for maintaining the trans-sarcolemmal sodium gradient that drives ion exchange and transport processes that are critical for cardiac function. The 72-residue phosphoprotein phospholemman regulates the sodium pump in the heart: unphosphorylated phospholemman inhibits the pump, and phospholemman phosphorylation increases pump activity. Phospholemman is subject to a remarkable plethora of post-translational modifications for such a small protein: the combination of three phosphorylation sites, two palmitoylation sites, and one glutathionylation site means that phospholemman integrates multiple signaling events to control the cardiac sodium pump. Since misregulation of cytosolic sodium contributes to contractile and metabolic dysfunction during cardiac failure, a complete understanding of the mechanisms that control the cardiac sodium pump is vital. This review explores our current understanding of these mechanisms.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号